117 S4633 IS: To improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions. U.S. Senate 2022-07-27 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

II117th CONGRESS2d SessionS. 4633IN THE SENATE OF THE UNITED STATESJuly 27, 2022Mr. Brown (for himself and Mr. Scott of South Carolina) introduced the following bill; which was read twice and referred to the Committee on FinanceA BILLTo improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions.

1.

Guidance relating to Medicaid coverage of genetic testing to improve outcomes for beneficiaries with major depressive disorder or other mental health conditions

Not later than 1 year after the date of enactment of this Act, the Administrator of the Centers for Medicare & Medicaid Services shall issue guidance for State Medicaid programs through a State Medicaid Director letter that specifies best practices to improve outcomes for individuals eligible for medical assistance under State Medicaid programs who have major depressive disorder or other mental health conditions. The guidance shall include coverage policy examples utilizing pharmacogenetic testing to support clinicians seeking medication options to treat patients and reduce trial and error from the Medicare program or from issuers of individual or group health insurance coverage.